Veronica DeFelice the Director of Bologic Products at Sapio Sciences. Veronica is a subject matter expert in end-to-end antibody therapeutics, spanning research, development, and commercialization. Early in her career, she contributed to groundbreaking peptide research at the Archipelagos Institute of Biology in Greece and advanced foundational biologics work in lipid nanoparticles (LNP) and cell and gene therapy. Throughout her career, Veronica has led cross-functional teams and driven innovative biologic informatics solutions. She played a key role in advancing AI-driven drug development at AICure and Nurix Therapeutics, accelerating antibody candidates through preclinical phases. At Sartorius and other organizations, she has transformed biologics platforms and collaborated with R&D teams to translate scientific needs into informatics solutions, expanding antibody discovery and optimization capabilities.
The gene-to-protein workflow represents one of molecular biology’s most fundamental processes, allowing scientists to express and study proteins of...
Read Post
Learn more about How to Create a Gene to Protein Workflow
The pace of antibody discovery continues to accelerate, and with it comes increasing complexity in managing experimental workflows, large...
Read Post
Learn more about Streamlining Antibody Discovery Workflows with an Integrated Laboratory Informatics Platform